Replacement of diseased heart valves remains a challenge for the cardiac surgeon. There is no ideal substitute yet available for valve replacement, mainly because of the remarkable properties and capabilities of living valve tissue.
Clinical experience with prosthetic valves has shown satisfactory results over a period of six to eight years, but their use is still associated with complications and accidents that are difficult to avoid. Among the complications connected with prosthetic valve replacement thromboembolism, impaired haemodynamic function, destruction of red calls, mechanical failure, haemorrhage, and infection are the most important.
To obviate the drawbacks of prosthetic valves, free homografts (Ross, 1962 (Ross, , 1967a BarrattBoyes, 1964) and heterografts (Binet, Duran, Carpentier, and Langlois, 1965; O'Brien, 1967) have been used with success for replacement of the aortic valve.
For mitral and tricuspid replacement, heterologous aortic valves (lonescu, Wooler, Smith, and Grimshaw, 1967; Ionescu, Wooler, Whitaker, Smith, Taylor, and Hargreaves, 1968; Carpentier, Blondeau, Laurens, Mancel, Laurent, and Dubost, 1968) and homologous aortic valves (Angell, Stinson, Iben, and Shumway, 1968) attached to a supporting frame have been used successfully over the past three years.
There are many advantages of homo-and heterografts compared with mechanical prostheses, the two main ones being the absence of thromboembolism and a near normal haemodynamic result.
In the majority of cases the grafts used are non-viable, sterilized, preserved tissues. Their longterm fate is uncertain despite the fact that some are functioning satisfactorily up to seven years post-operatively.
There is particular concern about late calcification, fibrous thickening of the cusps, and late disintegration of the cusp tissue (Duran, Manley, and Gunning, 1965; Hudson, 1966; Ross, 1967a; Smith, 1967; Brock, 1968) .
Almost all non-viable homograft valves removed from patients after implantation in the aortic root had acellular cusps (Hudson, 1966; Smith, 1967; Ross, personal data) , while the majority of non-viable heterografts were seen to contain cells six to eight months after implantation in the mitral annulus (Sutherland and Ionescu, personal data) .
This difference in the reaction of the host is not understood. It may be due to the fact that the mitral annulus is more vascular than the aortic. Also it is not known whether the cellular infiltration seen in heterologous grafts is beneficial or not to the graft. Lower, Pillsbury, Angell, and Kosek (1966) consider that freeze-dried or sterilized tissues do not provide an effective latticework for host replacement, and the findings in other published reports support this opinion.
It appears likely that there is a difference in host reaction to fresh and treated material, presumably due to denature of some of the proteins from the graft by freeze-drying and reconstitution and also to alteration of the electrical potential in the dead graft.
These theoretical speculations together with clinical and pathological findings support the statement that 'there is not a single instance where an autograft is not superior to a homograft as grafting material' (Peer, 1955) .
In an attempt to improve long-term fate, Ross (1967b) Stimulated by Senning's results we developed a technique of heart valve replacement with autologous fascia lata attached to a supporting frame to be used in the mitral, tricuspid, and aortic positions (Ionescu and Ross, 1969;  Ionescu, Ross, Holden, Hargreaves, and Wooler, 1970) . This paper both outlines the techniques of preparation and surgical implantation of the fascia lata graft into these three positions and presents our early results with 76 patients operated upon since April 1969 at the General Infirmary at Leeds and the National Heart Hospital and Guy's Hospital, London.
PREPARATION OF FASCIA LATA GRAFTS
The method employed in making the valve is basically the same for all three positions. The supporting frame consists of a thin-walled titanium stent with a scallopshaped ring and three narrow prongs, each with two perforations close to the free end for suture attachment of the fascia commissures. This titanium frame is entirely covered both inside and outside with Dacron velour.1 The large suturing skirt is reinforced inside with a Dacron felt2 rim (Fig. 1) .
Sizes from 26 to 32 mm. internal diameter are available for the mitral and tricuspid positions; the sizes for subcoronary insertion vary from 16 to 26 mm. inside diameter. For paediatric use frames with an inside diameter of 22 and 24 mm. are available.2 FIG. 1. Supporting frame for fascia lata valve grafts.
The titanium structure is covered with Dacron velour and provided with a large suturing rim.
Immediately after the patient has been anaesthetized a strip of fascia lata is removed from the lateral aspect of the thigh. This should be a little larger than is considered necessary in order to choose a part without vascular perforations (Table I) . 72  15  13  22  18  78  16  15  24  20  84  18   17  26  22  91  21  19  28  24  97  22  21  30  26  104  23  23  32  28  111  24  25  34  30  117  25  27  36  32  123  27  29  38 Both surfaces of the fascia are trimmed, and fat and loose connective tissue is removed. In order to obtain a suitable rectangular piece, the fascia is measured and cut in such a way as to have one margin parallel to the direction of the longitudinal fibres. The two ends of the fascia strip are sutured together along two-thirds of their width using a double continuous 4-0 stitch. This will make the fascial strip into a cylinder. The edge which has been cut along the longitudinal fibres is placed uppermost to become the free margin of the cusps. This edge is marked with three 5-0 stitches at equidistant points using a Teflon cone as a guide (Fig. 2) (Fig. 3) .
After attaching the commissural points to the frame, the fascial tissue is moulded in such a way as to produce three equal cusps. While maintaining with a finger the position of each newly created cusp, the lower end of the fascia is stitched with a continuous 4-0 Mersilene suture to the scallop-shaped margin of the frame (Fig. 4) . The redundant tissue at this lower margin is removed and the valve is ready for implantation (Fig. 5) In the subcoronary position, the frame-supported fascia graft is sutured as easily and as rapidly as a Starr prosthesis. We favour anoxic arrest of the heart at euthermic level because the whole intracardiac procedure usually takes less than 45 minutes (Fig. 8) Concerning the process of collagenous fibre formation, Stearns (1940) Clark (1952) and Cowdry (1950) , the developmental origin of elastic fibres is still obscure. They appear to be made from the alignment of refractile granules laid down in the intercellular matrix by some unknown agency. The probability is that they are not formed by the fibroblast.
There is no evidence that new elastic fibres can be produced when they have been destroyed, and it seems possible that the original fibres last through the individual's lifetime.
Elastic fibres may survive free transplantation and may remain during the life-span of the human recipient (Peer, 1955 (1901, 1904) , who used strips of aponeurosis as suture material in the repair of herniae, and Murphy (1904) , who used pedicle transplants of fascia in arthroplasty. Kirschner (1909) reported the successful use of autogenous fascia grafts in animals and stated that the transplants retained their structure after transfer and remained in the host area as living tissue. This report stimulated a great interest for further experimental and clinical work. Kirschner (1910) was probably the first to transplant fascia in humans and later expose the grafts and observe that grossly the transplants had not been absorbed and that they appeared exactly like fascia. McArthur (1913) showed microscopically that 'cells supplied with sufficient appropriate plasma, under conditions approximating those of life, will live and multiply, each retaining its own particular characteristic'. He made a statement which is more accurate than many later statements by others on the behaviour of free autografts, namely, that 'under aseptic conditions almost any autogenous graft may remain viable in any other part of the donor's anatomy'. Shaw (1915) held that for the first few days a transplant must obtain its chief nourishment from lymph exudate supplied by the surrounding tissues, and eventually from vascular connections. Therefore the less vascular the transplant is and the more vascular the soil, the greater is the assurance of success.
In 1916 Wierzejewski noted that without mechanical demand fascia maintains its structure but it shrinks about one-fifth to one-sixth in volume. Lewis (1917) considered fascia an ideal material for transplantation ; being thin, it is easily permeated by serum and it undergoes little or no degenerative change after direct transplantation. Neuhof (1923) maintained that in not a single instance had transplanted fascia been extruded, not even in patients in whom infection had been present or had appeared post-operatively.
In careful experimental work with rabbits, Gallie and LeMesurier (1921) demonstrated that the fibroblast cells in autogenous fascia grafts remained viable after transplantation and that the graft retained its usual structure.
Gallie (1948) and Gallie and LeMesurier (1921, 1922, 1924) In later work, Gallie and LeMesurier (1948) and Gallie (1948) made microscopic examinations of autogenous fascia grafts buried in humans for six and 10 years respectively, and noted that grossly and histologically the graft structure resembled that of normal fascia. Bunnell (1928) agreed with Gallie and LeMesurier in the belief that autogenous fascia grafts remained viable following successful transplantation. Foshee (1943 Foshee ( , 1947 , in studies concerning the removal of fascia lata in about 300 individuals, observed a bulge of the thigh muscles for a few months, which disappeared after six months in every patient who had been followed up.
Fascia lata regenerates to fill a defect in a donor area where fascia has been removed. Chandy (1946) Peer (1955) buried autogenous fascia lata grafts in human abdominal fat and removed the grafts at different intervals from 24 hours to 12 years. At four months and 18 months the fascia grafts had an entirely normal appearance, except that there were about twice as many fibroblasts present as are seen in normal control fascia. The appearance and arrangement of the collagenous fibres were identical with those of normal fascia. Mass infiltration by host fibroblasts into the structure of the graft was not evident.
The same author's experimental work with preserved homologous fascia grafts in humans indicates considerable reaction to the graft, possibly on an antigen-antibody basis. The host's blood vessels and fibroblasts grew into the graft structure, and the fibroblasts and blood vessels of the graft disappeared. Large cellular infiltrations of the inflammatory type were present within and outside the graft up to eight months after transplantation. Pullinger and Pirie (1942) implanted strips of fascia lata beneath the facial skin as autologous grafts. When removed one year later no cellular activity was noted around them; they retained their original structure even microscopically.
The influence of functional activity on the healing of tendon has been widely studied since 1891, when Viering showed that functional stimulation influenced the orientation of cells in healing tendon. He showed further, and Schwarz (1922) confirmed, that non-specialized connective tissue transplanted into a tendon defect gradually assumed a tendon-like structure if it were subjected to a functional stimulus.
The analogy between tendon and fascia gives even more support to the theory of fascia behaviour after autotransplantation because tendon is a somewhat more complicated tissue containing two types of parenchymal cells.
On theoretical grounds, another interesting parallelism could be presented to support the idea that a simple structure, possessing a unique type of parenchymal cell scattered in a large mass of fibres and ground substance, survives after autotransplantation and retains its structural and functional properties indefinitely (Gibson, 1968) . The chondrocyte is the only parenchymal cell of cartilage. It is a versatile cell which alone is responsible for the elaboration of the matrix which surrounds it. It is also a very active cell, continuously 'servicing' the matrix. In addition, cartilage transplanted homogeneically survives if the chondrocytes survive transplantation (Leopold, 1881) . This phenomenon of not provoking an immune response seems to be unique. Gibson, Davis, and Curran (1958) , in a series of experimental cartilage homografts in man, found the chondrocytes actively metabolizing sulphur throughout the two-year period of the experiment.
Later Gibson and Davis (1960) demonstrated living chondrocytes in a graft of a mother's ear cartilage transplanted to her child 18 years previously.
That these living cells are the original chondrocytes and not host cells repopulating the matrix is apparent from two facts first, chondrocyte repopulation of dead cartilage is never observed; secondly, Peer (1958) showed that the sex chromatin structure of the surviving cells is that of the donor.
Concerning heart valve replacement, fascia lata has been used only during the last few years.
Flege, Rossi, Auer, and Ehrenhaft (1967) (Peer, 1955 (Woodruff, 1960) .
In transplants of more complex structure, populated by cells of various kinds, some of which survive transplantation while others do not, the structure of the transplanted tissue is permanently altered. Both fascia and cartilage retain their structure unaltered after transplantation because they are unicellular tissues.
Since intercellular substances are usually interposed between capillaries and the cells which they nourish, all, regardless of their apparent density, must permit diffusion of substances from capillaries to cells and vice versa. This takes place even more easily when the transplanted tissue lies in the blood stream and is penetrated by the nourishing fluid under pressure, as happens in heart valve replacement. The immediate results obtained with our patients are very good, but the follow-up period is too short to draw any conclusion concerning the long-term fate of autologous fascia lata valve grafts. However, Senning's (1967) good results with fascial grafts for aortic valve replacement demonstrate that fascia lata remains viable and well preserved years after transplantation. Our clinical results with mitral, aortic, and tricuspid valve replacement using autologous fascia lata valves mounted on to support frames showed a perfect haemodynamic function, absence of thromboembolic phenomena without anticoagulant treatment, and simplicity in the preparation and implantation of these valves. We consider that fascia lata valves could ultimately be superior to homoand heterografts for heart valve replacement because they are made of autologous, living tissue, which maintains its structure unchanged after transplantation. The fascia matrix is 'serviced' by living fibroblasts and, being under continuous mechanical stimulation, it retains its functional properties.
CONCLUSIONS
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Since this article was completed a further 75 patients have had heart valves replaced with autologous fascia lata grafts, bringing the total number to 151.
In 62 patients the mitral valve was replaced, in 49 the aortic, in 4 the tricuspid, in 24 the mitral and aortic valves, in 6 the mitral and tricuspid valves, and 6 patients had mitral, aortic and tricuspid valve replacement. Twenty-eight patients died during the hospital stay (18-50 hospital mortality).
As late complications 3 patients developed subacute bacterial endocarditis a short time after surgery, 4 have a diastolic aortic murmur, and 4 a systolic mitral murmur. These murmurs do not have haemodynamic implications so far, the patients being in a very good condition. Concerning the systolic murmur in mitral valve replacement we suspect that this murmur is produced by the fascia lata graft not being positioned high enough into the left atrium and obstructing partially the outflow tract of the left ventricle. This technical error should be seen and corrected at the time of surgery. The remaining patients are doing extremely well with a follow-up since April 1969.
